콘텐츠로 건너뛰기
Merck
  • [Antibiotic strategy in bronchial infections. Role of roxithromycin].

[Antibiotic strategy in bronchial infections. Role of roxithromycin].

Presse medicale (Paris, France : 1983) (1997-03-01)
J Gaillat
초록

BRONCHIAL SUPERINFECTIONS: Macrolides are first-line antibiotics for acute bronchitis and infectious complications of chronic bronchitis. Data in the literature on roxithromycin treatment in respiratory tract infections demonstrate to clinical and bacteriological efficacy at high doses comparable with other available antibiotics. ANTIBIOTIC STRATEGY: These results are explained by the bioavailability of roxithromycin, its antibacterial spectrum, and its pharmacokinetic features (high serum peak, high intracellular and extracellular concentrations).

MATERIALS
제품 번호
브랜드
제품 설명

Roxithromycin, European Pharmacopoeia (EP) Reference Standard
Roxithromycin for system suitability, European Pharmacopoeia (EP) Reference Standard